The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $111.41

Today's change+0.15 +0.13%
Updated July 29 1:51 PM EDT. Delayed by at least 15 minutes.
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $111.41

Today's change+0.15 +0.13%
Updated July 29 1:51 PM EDT. Delayed by at least 15 minutes.

Celgene Corp Hits New 100-day High

Celgene Corp is up today by (U.S.)$0.15 or 0.13% to (U.S.)$111.41 and setting a new 100-day high. Over the last five days, shares have gained 3.62%, but are down 6.97% for the last year to date. Shares have underperformed the S&P 500 by 18.83% during the last year.

Key company metrics

  • Open(U.S.) $110.66
  • Previous close(U.S.) $111.26
  • High(U.S.) $111.95
  • Low(U.S.) $110.50
  • Bid / Ask(U.S.) $111.40 / (U.S.) $111.42
  • YTD % change-6.97%
  • Volume3,361,865
  • Average volume (10-day)4,935,989
  • Average volume (1-month)5,073,873
  • Average volume (3-month)4,501,353
  • 52-week range(U.S.) $92.98 to (U.S.) $136.40
  • Beta1.23
  • Trailing P/E53.90×
  • P/E 1 year forward19.53×
  • Forward PEG0.90×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.07
Updated July 29 1:51 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue2,5122,5632,3342,278
Total other revenue--------
Total revenue2,5122,5632,3342,278
Gross profit2,4062,4582,2242,177
Total cost of revenue106105110101
Total operating expense1,4881,6852,2761,865
Selling / general / administrative543609550617
Research & development7337771,3051,110
Depreciation / amortization92886464
Interest expense (income), net operating--------
Unusual expense (income)14105248-26
Other operating expenses, total--------
Operating income1,02487958412
Interest income (expense), net non-operating-135-139-105-64
Gain (loss) on sale of assets--------
Other--------
Income before tax922746-20471
Income after tax801561-34356
Income tax, total12118514115
Net income801561-34356
Total adjustments to net income--------
Net income before extra. items801561-34356
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items801561-34356
Inc. avail. to common incl. extra. items801561-34356
Diluted net income801561-34356
Dilution adjustment--------
Diluted weighted average shares808817791825
Diluted EPS excluding extraordinary itemsvalue per share0.990.69-0.040.43
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.010.780.160.41